ICH Project ICH S1B (R1): Briefing on the draft guideline "Addendum to the Guideline on Carcinogenicity Studies of Pharmaceutical Products" which reached Step 2

Jul 28, 2021

ICH S1B(R1) "Addendum to the Guidelines for Carcinogenicity Studies of Drugs" has reached Step 2, and a briefing session was held jointly by the Japan Pharmaceutical Manufacturers Association (JPMA), the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA).

The End